SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-053934
Filing Date
2024-05-07
Accepted
2024-05-07 07:15:13
Documents
18
Period of Report
2024-05-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eldn-20240506.htm   iXBRL 8-K 50419
2 EX-4.1 eldn-ex4_1.htm EX-4.1 128774
3 EX-10.1 eldn-ex10_1.htm EX-10.1 487521
4 EX-10.2 eldn-ex10_2.htm EX-10.2 264066
5 EX-99.1 eldn-ex99_1.htm EX-99.1 10787
6 EX-99.2 eldn-ex99_2.htm EX-99.2 18912
7 GRAPHIC img20068692_0.jpg GRAPHIC 7613
8 GRAPHIC img20992213_0.jpg GRAPHIC 14427
  Complete submission text file 0000950170-24-053934.txt   1236708

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eldn-20240506.xsd EX-101.SCH 24851
21 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20240506_htm.xml XML 4703
Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 24919593
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)